A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses

OBJECTIVE: Differentiation between benign and malignant ovarian neoplasms is essential for creating a system for patient referrals. Therefore, the contributions of the tumor markers CA125 and human epididymis protein 4 (HE4) as well as the risk ovarian malignancy algorithm (ROMA) and risk malignancy...

ver descrição completa

Detalhes bibliográficos
Autor principal: Anton, Cristina (author)
Outros Autores: Carvalho, Filomena Marino (author), Oliveira, Elci Isabel (author), Maciel, Gustavo Arantes Rosa (author), Baracat, Edmund Chada (author), Carvalho, Jesus Paula (author)
Formato: article
Idioma:eng
Publicado em: 2012
Assuntos:
Tumor Markers
Biological
Ovarian Neoplasms
CA 125 Antigen
Epididymal Secretory Proteins
Risk Assessment
Sensitivity and Specificity
Texto completo:https://doi.org/10.6061/clinics/2012(05)06
País:Brasil
Oai:oai:revistas.usp.br:article/40121

Texto Completo

https://doi.org/10.6061/clinics/2012(05)06

Registros relacionados